In the conclusion of a two-part interview, Haleon CEO Brian McNamara and Lisa Paley, president of the O-T-C supplier’s North American business, discuss the self-care category’s standing in a post-COVID world. Among the issues addressed are the continued importance of Rx-to-O-T-C switches, steps that the company is taking to fuel innovation, and the need for both science and human understanding in shaping the business.
Video Forum: Brian McNamara & Lisa Paley, Haleon
Related
2024 NACDS TSE welcomes NACDS chain and supplier members to Boston
NACDS Leaders: Pharmacy is a catalyst for change and innovation, and NACDS TSE is where it happens.
Walmart says a new era of 'Adaptive Retail' is here
Walmart commissioned Morning Consult to conduct a survey of more than 2,200 U.S. shoppers.
Census data shows modest sales gains in June
WASHINGTON – Data released by the U.S. Census Bureau shows modest retail sales gains in June despite an uneven pace of spending in recent months, National Retail Federation chief economist Jack Kleinhenz said. “The path of household spending remains difficult to read,” Kleinhenz said.
FTI says online retail sales to hit $1.2 Trillion
U.S. online retail sales will reach $1.2 trillion in 2024, up nearly 10% from last year, according to FTI Consulting’s 2024 Online Retail Report. The firm’s Retail & Consumer Products practice, which conducted analysis for the report, expects U.S. e-commerce sales to account for 22.
Latest
Dollar General expands role of Matthew Simonsen
One of three personnel moves in business intelligence and store operations.
Retail sales rise in November as holiday spending stays on track with NRF's forecast
"Retail sales showed healthy year-over-year gains in November while month-over-month data was largely flat,”
Costco delivers strong first quarter, fueled by membership growth and E-commerce surge
Comparable sales climbed 6.4%, topping analysts’ expectations of 5.8%.
CRN praises FDA for clarifying DSHEA disclaimers’ placement
The Council for Responsible Nutrition commended the FDA for clarifying how companies can place the Dietary Supplement Health and Education Act disclaimer on labels.